Salvage Chemotherapy in Patients with Previously Treated Thymic Carcinoma
Thymic carcinoma is a rare neoplasm, and it is difficult to achieve complete remission with systemic chemotherapy. In advanced or recurrent thymic carcinoma, platinum-based chemotherapy is chosen as the first-line setting; however, it remains unclear which regimen is better to improve its outcome. I...
Guardado en:
Autores principales: | Kyoichi Kaira, Hisao Imai, Ou Yamaguchi, Atsuto Mouri, Hiroshi Kagamu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e86fe81e069a415a9bad607ca2328647 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Effectiveness of Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer with a Poor Performance Status
por: Kyoichi Kaira, et al.
Publicado: (2021) -
Changes in Treatment Patterns and Globe Salvage Rate of Advanced Retinoblastoma in Korea: Efficacy of Intra-Arterial Chemotherapy
por: Dong Hyun Lee, et al.
Publicado: (2021) -
Growth hormone in the presence of laminin modulates interaction of human thymic epithelial cells and thymocytes in vitro
por: Lins,Marvin Paulo, et al.
Publicado: (2016) -
Multiplex Genetic Engineering Exploiting Pyrimidine Salvage Pathway-Based Endogenous Counterselectable Markers
por: Lukas Birštonas, et al.
Publicado: (2020) -
The investigation of salvage endoscopic laryngopharyngeal surgery after chemoradiotherapy
por: Yohei Kawasaki, et al.
Publicado: (2020)